A model to assess interventions to improve collateral blood flow: continuous administration of agents into the left coronary artery in dogs.

Unger, E F; Banai, S; Shou, M; Jaklitsch, M; Hodge, E; Correa, R; Jaye, M; Epstein, S E

Unger, E F; Banai, S; Shou, M; Jaklitsch, M; Hodge, E; Correa, R; Jaye, M; Epstein, S E.

Affiliation

Unger EF; Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

Cardiovasc Res ; 27(5): 785-91, 1993 May.

Article in En | MEDLINE | ID: mdl-7688663

Subject(s)

Collateral Circulation/drug effects; Coronary Circulation/drug effects; Disease Models, Animal; Fibroblast Growth Factor 1/pharmacology; Animals; Dogs; Female; Heparin/pharmacology; Infusions, Intra-Arterial; Male; Neovascularization, Pathologic; Regional Blood Flow/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Fibroblast Growth Factor 1 / Collateral Circulation / Coronary Circulation / Disease Models, Animal Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cardiovasc Res Year: 1993 Type: Article

Search on Google

XML

PubMed Links